Tuesday, January 16, 2018 -- NewsRoche’s Ocrevus (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.Contributed Author: Roche Holding AG
Saturday, January 20, 2018 -- (MedPage Today) -- Which is better for detecting synovitis?
Saturday, January 20, 2018 -- (MedPage Today) -- DLN likely to become more common with rising life expectancy in SLE
Friday, January 19, 2018 -- ImmuPharma has completed its 52-week, randomised, double-blinded, phase 3 clinical trial of Lupuzor, its lead candidate for the potential breakthrough compound for Lupus.
Tuesday, January 16, 2018 -- RA-specific factors may predispose individuals to developing COPD independent of smoking.